Treatment Outcome – HCV Guidance

Treatment of chronic hepatitis C in a state correctional facility

April 9, 2018
Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis

December 8, 2017
Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings

August 30, 2017
Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C

June 16, 2017
Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials

June 16, 2017
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection

May 23, 2017
Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection

May 23, 2017
Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease

May 23, 2017
Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network

May 23, 2017
Effects of viral eradication with ledipasvir and sofosbuvir, with or without ribavirin, on measures of fatigue in patients with chronic hepatitis C virus infection

May 18, 2017